• Washington Post: scarcity of biotech ingredients

    10 days ago - By Green Light Biosciences

    Andrey Zarur, CEO of GreenLight Biosciences, spoke to The Washington Post about the scarcity of biotech ingredients and the impact on Covid-19 vaccine supply.
    Credit: James MacDonald/Bloomberg News
    Andrey Zarur, CEO of GreenLight Biosciences, spoke to The Washington Post about the scarcity of biotech ingredients and the impact on Covid-19 vaccine supply. An extract from the articles is below:
    Pfizer-BioNTech made agreements this month for more supply from two German companies, but that new capacity will not come online for months. One of those German suppliers, Merck KGaA (which is not...
    Read more ...